Asthma gene variants may cut risk of brain cancer

	Tweet

New research suggests that gene variants, which are known to raise the risk of Asthma, decrease the risk of glioblastoma multiforme (GBM) , a common type of brain cancer that is rapidly fatal.

Variants or “polymorphisms” are minor changes in a gene that can influence how often the associated protein is produced in a cell and how well it functions.

Several reports have linked Asthma with a reduced risk of brain tumors, but the studies may have suffered from various design issues, said lead author Dr. Judith Schwartzbaum, from Ohio State University in Columbus. “So, to me, the evidence just wasn’t credible.”

In the present study, Schwartzbaum’s team looked for an association between asthma-related gene variants and GBM in a study of 111 patients with this tumor and 422 comparison subjects. An extensive literature search was conducted to identify variants that have been consistently linked to an increased or decreased risk of Asthma.

In agreement with previous findings, self-reported asthma was associated with a decreased risk of GBM, the researchers note in the journal Cancer Research.

Two variants were tied to a heightened risk of GBM, whereas another was associated with a reduced risk. As it turns out, the two former variants are known to decrease the risk of asthma, whereas the latter raises the risk.

“Now I’m interested in determining if these polymorphisms just happen to have independent roles in the two diseases or does having Asthma or allergy symptoms reduce the risk of GBM," Schwartzbaum said.

“I’d also like to find a polymorphism that increases the risk of both diseases,” rather than raises the risk of one and lowers the risk of the other. Such a variant could serve as a target for new drugs, she explained.

SOURCE: Cancer Research, July 15, 2005.

RELATED STORIES:
Penn Study on Silencing of Tumor Suppressor Gene Suggests New Target for Lymphoma   Imaging Technology May Relieve Cancer Pain   Broccoli, cauliflower and cabbage help repair damaged DNA   New study widens cancer risks and benefits of pill   Drug Therapy to Bolster Immune System Cells Found Effective Toward Childhood Cancer   Lilly brain cancer drug promising in small study   Biomedical Researcher Uses Ultrasound to Measure Early Response to Cancer Treatment   Health literacy tests underutilized; may improve elderly cancer patients’ care and outcomes   A tonic against non-Hodgkin lymphoma?   Mount Sinai researchers discover possible new target for sarcoma treatment and prevention   Gene Therapy Anti-cancer Work Featured in Scientific American   Free prescriptions over cancer   Small Gift Makes Big Impact in Lives of Cancer Patients   Jews who survived wartime Europe have more cancer   Women underrepresented in most cancer research   Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds   Drug combo boosts Pancreatic cancer survival - study   Body’s own cells a new way to fight cancer   U.S. study faults aggressive end-of-life cancer care   New computational tool for cancer treatment   Most cancer victims unaware of anti-angiogenesis   Identifying subsets of patients who will respond to subsequent lines of chemotherapy

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]